Urgent.News

the world's headlines, one feed

Health & Medicine

STAT+: FDA approves Replimune melanoma drug previously rejected twice

The FDA approved Replimune’s treatment for advanced melanoma, dealing the company and patient advocates a big win after a tumultuous saga.

STAT+: FDA approves Replimune melanoma drug previously rejected twice

We haven't written up this one. STAT News has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at statnews.com →

More in Health & Medicine